Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07946978
NA

A Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood Sugar

Sponsor: Etta Vita

View on ClinicalTrials.gov

Summary

This study evaluates the effects of the Etta Vita GLP-1 supplement on appetite, gut health, and blood sugar over a 12-week period. Thirty participants with a BMI of 25 or greater and experiencing at least two of the following issues - food cravings, poor appetite control, irregular bowel movements, bloating, or gut issues - will use the test product daily. The trial is a single-arm, open-label study in which all participants take two capsules of the supplement each morning, no more than 15 minutes before their first meal. Participants complete questionnaires at Baseline, Week 4, Week 8, and Week 12, and attend their local clinic for blood tests (HbA1c, Glucose, and Leptin) at Baseline and Week 12.

Key Details

Gender

All

Age Range

21 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-04-01

Completion Date

2026-08-30

Last Updated

2026-11-18

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Etta Vita GLP-1 Supplement Intervention

All 30 participants receive the Etta Vita GLP-1 supplement (two capsules taken orally each morning, no more than 15 minutes before the first meal of the day) for 12 weeks.

Locations (1)

Citruslabs

Las Vegas, Nevada, United States